sarilumab
Selected indexed studies
- Sarilumab. (, 2012) [PMID:31643297]
- Sarilumab. (, 2006) [PMID:29999974]
- Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. (N Engl J Med, 2023) [PMID:37792612]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Sarilumab. (2012) pubmed
- Sarilumab. (2006) pubmed
- Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. (2023) pubmed
- Sarilumab (Kevzara®). (1994) pubmed
- Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trial. (2025) pubmed
- Sarilumab: First Global Approval. (2017) pubmed
- Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters. (2021) pubmed
- Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations. (2022) pubmed
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. (2023) pubmed
- Sarilumab: patient-reported outcomes in rheumatoid arthritis. (2018) pubmed